Fundz

Rhaeos, Inc. Strengthens Leadership Team with Appointment of Dr. David Limbrick as Chief Medical Officer

PRIVATENov 28, 2023

Position

Chief Medical Officer

Company

Rhaeos

David Limbrick
EvanstonBiotechnologyHealth CareMedicalMedical Device

Description

Rhaeos, Inc., a clinical-stage medical device technology company dedicated to advancing diagnostic solutions for hydrocephalus patients, proudly welcomes David D. Limbrick, Jr., MD, PhD, as its new Chief Medical Officer .

Quick answer

Rhaeos, Inc. Strengthens Leadership Team with Appointment of Dr. David Limbrick as Chief Medical Officer (November 28, 2023). Rhaeos is based in Evanston, Illinois, United States.

Who is the new Chief Medical Officer at Rhaeos?
Rhaeos named David Limbrick Chief Medical Officer, announced November 28, 2023.
What did Rhaeos announce on November 28, 2023?
Rhaeos, Inc., a clinical-stage medical device technology company dedicated to advancing diagnostic solutions for hydrocephalus patients, proudly welcomes David D. Limbrick, Jr., MD, PhD, as its new Chief Medical Officer .
What does Rhaeos do?
Rhaeos, Inc. is a pioneer in medical device wearables for hydrocephalus, with its groundbreaking FlowSense technology designed to monitor cerebrospinal fluid shunt function rapidly and non-invasively.
Where is Rhaeos based?
Rhaeos is based in Evanston, Illinois, United States.
Which similar companies made leadership changes around the same time?
Caldera Medical (December 5, 2023), Prytime Medical Devices (November 21, 2023), Medical Facilities Corporation (November 20, 2023) and NeuroOne Medical Technologies Corporation (November 18, 2023) also announced leadership changes within 45 days of Rhaeos.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rhaeos, and when

A new leader at Rhaeos brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rhaeos raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rhaeos, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rhaeos. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rhaeos

Location

Evanston, Illinois, United States

About

Rhaeos, Inc. is a pioneer in medical device wearables for hydrocephalus, with its groundbreaking FlowSense technology designed to monitor cerebrospinal fluid shunt function rapidly and non-invasively. Developed from the world-renowned John A. Rogers Research Group at Northwestern University, the FlowSense system utilizes a small, bandage-sized patch adhered to a patient's skin over the implanted shunt tubing. This FDA breakthrough designated technology wirelessly transmits critical data on shunt functionality to a mobile app within minutes, providing clinicians with real-time information to optimize treatment plans. Rhaeos is a private medical technology company spun out of Northwestern University and is focused on developing wearable sensors to improve the care of people suffering from chronic and difficult-to-treat conditions. The company's novel FlowSense shunt monitor is a non-invasive, wireless, thermal sensor that addresses a clinical unmet need for people with hydrocephalus and is funded by the Steele Foundation for Hope, National Institute of Neurological Disorders and Stroke at the National Institutes of Health, National Science Foundation, MedTech Innovator, the Pediatric Hydrocephalus Foundation, the Southwest Pediatric Device Consortium, the National Capital Consortium for Pediatric Device Innovation, the UCSF-Stanford Pediatric Device Accelerator, the The Consortium for Technology & Innovation in Pediatrics, and public, private, and institutional investors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rhaeos changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alex
Likely contact at this company
••••••••@••••••••

See Alex's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Rhaeos's next move

Learn about Strategic plan

Rhaeos changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.